Seven of the heritable methylation marks associated with prostate cancer risk are located at peptidase M20 domain containing 1 (PM20D1), a known methylation and expression quantitative trait locus associated with risk of Alzheimer’s disease. Here, PM20D1 is linked to prostate carcinoma.